Eolo Pharma
PrivateLast Round
Series A
Dec 31, 2019
Total Funding Raised
$2.7M
Momentum Score
50 /100
Company Overview
Eolo Pharma is a clinical-stage biotechnology company developing novel small-molecule therapies for the treatment of obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eolo Pharma Comps
Public and private peers based on sector, stage, and business model.
Eolo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 31, 2019 |
Key People
Founding team and executive leadership
Eolo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITES | Series A |
| Ficus Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 432% MoM, reaching 2.1K.
Eolo Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eolo Pharma's valuation, stock price, and market status.
